Published in AIDS Weekly, February 16th, 2004
The final marketing approval is expected to follow later this year.
The new formulation will reduce Viracept's pill count from 10 tablets per day to 4 tablets per day. Moreover, Viracept 625 mg is reported to offer a marked reduction in the occurrence of diarrhea and was clearly preferred by patients in a recent study.
"The new Viracept 625-mg formulation with less pills and less diarrhea is good news for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.